These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 836942)

  • 21. Clinical pharmacokinetics of phenylbutazone.
    Aarbakke J
    Clin Pharmacokinet; 1978; 3(5):369-80. PubMed ID: 359213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive quantitative and qualitative liquid chromatography-radioisotope-mass spectrometry analysis for safety testing of tolbutamide metabolites without standard samples.
    Tozuka Z; Aoyama S; Nozawa K; Akita S; Oh-Hara T; Adachi Y; Ninomiya S
    J Pharm Sci; 2011 Sep; 100(9):4024-36. PubMed ID: 21638282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metabolism, excretion, pharmacokinetics and tissue residues of phenylbutazone in the horse.
    Lees P; Taylor JB; Maitho TE; Millar JD; Higgins AJ
    Cornell Vet; 1987 Apr; 77(2):192-211. PubMed ID: 3568689
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Simultaneous determination of tolbutamide and its hydroxy and carboxy metabolites in plasma and urine by high-performance liquid chromatography.
    Keal J; Stockley C; Somogyi A
    J Chromatogr; 1986 May; 378(1):237-41. PubMed ID: 3733977
    [No Abstract]   [Full Text] [Related]  

  • 25. Determination of phenylbutazone and oxyphenbutazone in plasma and urine samples of horses by high-performance liquid chromatography and gas chromatography-mass spectrometry.
    Neto LM; Andraus MH; Salvadori MC
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):211-8. PubMed ID: 8738024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Screening, quantification, and confirmation of phenylbutazone and oxyphenbutazone in equine plasma by liquid chromatography-tandem mass spectrometry.
    You Y; Uboh CE; Soma LR; Guan F; Li X; Rudy JA; Chen J
    J Anal Toxicol; 2009; 33(1):41-50. PubMed ID: 19161668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. GLC determination of plasma levels of intact chlorpropamide or tolbutamide.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1976 Apr; 65(4):576-9. PubMed ID: 1271259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Simultaneous HPLC determination of tolbutamide, phenacetin and their metabolites as markers of cytochromes 1A2 and 2C6/11 in rat liver perfusate.
    Jurica J; Konecný J; Zahradníková LZ; Tomandl J
    J Pharm Biomed Anal; 2010 Aug; 52(4):557-64. PubMed ID: 20149568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Drug interactions in therapy using coumarin derivatives].
    Gugler R
    Internist (Berl); 1979 May; 20(5):238-44. PubMed ID: 376479
    [No Abstract]   [Full Text] [Related]  

  • 30. Drug displacement from protein binding: isolation of a redistributional drug interaction in vivo.
    McQueen EG; Wardell WM
    Br J Pharmacol; 1971 Oct; 43(2):312-24. PubMed ID: 5158200
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specimen handling in an HPLC determination of phenylbutazone and its major metabolites in plasma, avoiding degradation of the compounds.
    Franssen MJ; Tan Y; Freij I; Van Ginneken CA; Gribnau FW
    Pharm Weekbl Sci; 1986 Aug; 8(4):229-33. PubMed ID: 3763367
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rapid screening and confirmation for drugs and metabolites in racing animals by tandem mass spectrometry.
    Brotherton HO; Yost RA
    Am J Vet Res; 1984 Nov; 45(11):2436-40. PubMed ID: 6524741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liquid chromatography-electrospray mass spectrometry determination of carbamazepine, oxcarbazepine and eight of their metabolites in human plasma.
    Breton H; Cociglio M; Bressolle F; Peyriere H; Blayac JP; Hillaire-Buys D
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Dec; 828(1-2):80-90. PubMed ID: 16203183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Drug interaction during therapy with tolbutamide. The influence of some commonly used drugs on plasma level and half life in diabetic out-patients (author's transl)].
    Kolenda KD; Grille W; Johnsen K
    Med Klin; 1979 Dec; 74(50):1914-22. PubMed ID: 542176
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Implications of enzyme induction in drug toxicity studies.
    Welch RM; Harrison YE; Burns JJ
    Toxicol Appl Pharmacol; 1967 Mar; 10(2):340-51. PubMed ID: 4962253
    [No Abstract]   [Full Text] [Related]  

  • 36. Simple, rapid and micro high-pressure liquid chromatographic method for the simultaneous determination of tolbutamide and carboxy tolbutamide in plasma.
    Nation RL; Peng GW; Chiou WL
    J Chromatogr; 1978 Jul; 146(1):121-31. PubMed ID: 757962
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of phenylbutazone and its metabolites in the horse.
    Gerring EL; Lees P; Taylor JB
    Equine Vet J; 1981 Jul; 13(3):152-7. PubMed ID: 7297544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacokinetics in liver cirrhosis].
    Ackermann E
    Z Gesamte Inn Med; 1977 Jan; 32(1):29-33. PubMed ID: 855389
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simultaneous high-performance liquid chromatographic determination of suxibuzone and its metabolites in plasma and urine.
    Marunaka T; Shibata T; Minami Y; Umeno Y; Shindo T
    J Pharm Sci; 1980 Nov; 69(11):1258-61. PubMed ID: 7452452
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GLC determination of gamma-hydroxyphenylbutazone in plasma.
    Midha KK; McGilveray IJ; Charette C
    J Pharm Sci; 1974 Nov; 63(11):1751-4. PubMed ID: 4427237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.